Tag: CMS

Hospital groups ask US Senate for $35B in COVID-19 relief funds

Editor's Note Nine hospital groups have asked the US Senate to add $35 billion to COVID-19 relief legislation to help them deal with financial effects of the COVID-19 pandemic, the February 25 Fierce Healthcare reports. The $1.9 trillion COVID-19 relief bill passed by the House does not include a provider…

Read More

By: Judy Mathias
March 2, 2021
Share

More states report telehealth reimbursement laws

Editor's Note A Foley & Lardner survey finds that state telehealth reimbursement laws have significantly increased during the COVID-10 pandemic, but more can be done to address telehealth adoption barriers, the February 15 Revcycle Intelligence reports. More than 43 states and Washington, DC, have some telehealth statute for commercial payers,…

Read More

By: Judy Mathias
February 18, 2021
Share

Joint Commission conducting both virtual and onsite surveys in 2021

The Joint Commission stopped doing most onsite surveys and reviews from March 16 to May 31, 2020, in response to the COVID-19 pandemic. During that time, they developed processes for conducting offsite or virtual events, and as of mid-December, more than 1,200 offsite surveys and reviews had been conducted across…

Read More

By: Judith M. Mathias, MA, RN
February 17, 2021
Share

‘COVID effect’ leads to fewer cardiac surgeries, more deaths

Editor's Note The COVID-19 pandemic has resulted in a substantial decline in cardiac surgery volume and an unexplained increase in deaths after coronary artery bypass grafting (CABG), finds this study presented January 30 at the Annual Meeting of the Society of Thoracic Surgeons (STS). Researchers from the University of California,…

Read More

By: Judy Mathias
February 8, 2021
Share

Parsing COVID-19 transmission routes informs levels of protection needed

Information about COVID-19 transmission and treatment has evolved between the time this infectious disease first emerged and now. As evidence-based knowledge grows and protocols change, and as populations are vaccinated to develop herd immunity, there is increasing optimism about the ability to combat the virus. Meanwhile, it is important to…

Read More

By: Judith M. Mathias, MA, RN
January 19, 2021
Share

Supply chain strategies shift to meet pandemic-induced demands

Resiliency, a term that has cropped up repeatedly during the COVID-19 pandemic, is often considered a key defense against burnout. But it is also important in the context of the healthcare supply chain, says Ed Hisscock, senior vice president of supply chain management at Trinity Health, a 22-state healthcare system…

Read More

By: Elizabeth Wood
January 19, 2021
Share

Editorial

The rollout of COVID-19 vaccines starting in December 2020 was the one bright spot in an otherwise tragic year with a rapidly rising death toll currently over 385,000. Distribution of the 20 million doses promised by year end was thwarted by problems such as lack of coordination and lack of…

Read More

By: Elizabeth Wood
January 19, 2021
Share

New year brings some changes to quality reporting criteria

The 2021 Medicare Hospital Outpatient Prospective Payment System (OPPS)/ASC Final Payment Rule was released on December 1, 2020, and became effective as of January 1, 2021. Gina Throneberry, MBA, RN, CASC, CNOR, director of education and clinical affairs, Ambulatory Surgery Center Association (ASCA), summarized the status of Medicare regulations and…

Read More

By: Elizabeth Wood
January 19, 2021
Share

Pfizer/BioNTech vaccine reaches 141 of 145 first-day locations

Editor's Note The first batch of the Pfizer/BioNTech's newly authorized COVID-19 vaccine for emergency use reached 141 of 145 targeted locations on the first day of its national rollout, a Department of Health and Human Services spokeswoman told Reuters. Four island territories—American Samoa, Guam, North Mariana Islands, and the US…

Read More

By: Judy Mathias
December 15, 2020
Share

HHS purchases 100 million additional doses of Moderna’s COVID-19 vaccine

Editor's Note The Department of Health and Human Services (HHS) announced on December 11 that it would purchase 100 million additional doses of Moderna’s COVID-19 vaccine. The vaccine, which was developed by Moderna with scientists from the National Institute of Allergy and Infectious Diseases (NIAID), is scheduled for a December…

Read More

By: Judy Mathias
December 15, 2020
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat